Laurus Labs Ltd Quarterly Results
Q3 FY25-26 Results Summary
Revenue
The revenue stands at ₹1,778.29 crore, reflecting a quarter-on-quarter *(QoQ) increase of 7.55 per cent from ₹1,653.47 crore. This corresponds to a year-on-year *(YoY) growth of 25.67 per cent.
Operating Profit
Operating Profit stands at ₹480.21 crore, reflecting a quarter-on-quarter *(QoQ) increase of 19.08 per cent from ₹403.26 crore. This corresponds to a year-on-year *(YoY) growth of 68.41 per cent.
PBDT
PBDT stands at ₹445.95 crore, reflecting a quarter-on-quarter *(QoQ) increase of 14.07 per cent from ₹390.96 crore. This corresponds to a year-on-year *(YoY) growth of 86.51 per cent.
Profit Before Tax
Profit Before Tax stands at ₹325.33 crore, reflecting a quarter-on-quarter *(QoQ) increase of 20.28 per cent from ₹270.47 crore. This corresponds to a year-on-year *(YoY) growth of 144.59 per cent.
Net Profit
Net Profit stands at ₹251.88 crore, reflecting a quarter-on-quarter *(QoQ) increase of 29.51 per cent from ₹194.49 crore. This represents a 171.01 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Laurus Labs Ltd News
Laurus Labs Ltd Earnings
- YOY
- QOQ
Laurus Labs Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Laurus Labs Ltd Research Reports
Laurus Labs Ltd Financial Reports
Laurus Labs Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Laurus Labs | 0.79% | -2.42% | 11.06% | 14.13% | 13.56% | 82.43% |
| Aurobindo Pharma | -0.83% | -1.84% | 8.16% | 16.27% | 27.85% | 14.65% |
| Glenmark Pharma. | 0.88% | 3.80% | 13.72% | 20.28% | 28.80% | 75.73% |
| Alkem Lab | -0.79% | -2.66% | 1.25% | -5.34% | -2.78% | 5.05% |
| Biocon | 0.41% | 2.01% | 1.15% | -0.42% | -3.18% | 13.46% |
| Abbott India | 1.86% | 1.21% | -0.74% | -7.03% | -13.18% | -13.88% |
| Anthem Bioscienc | -0.34% | 4.12% | 17.48% | 28.82% | 7.49% | 5.57% |
Company Info
Company Information
Executive Director & CEO : CHAVA SATYANARAYANA
Executive Director & CFO : VENKATA RAVI KUMAR VANTARAM
Executive Director : Chandrakanth Chereddi
Director : Narendra Ostawal
Independent Director : Aruna Bhinge
Independent Director : Rajesh Koshy Chandy
Independent Director : Ramesh Subrahmanian
Company Secretary : G Venkateswar Reddy
Chairman : M Venu Gopala Rao
Independent Director : Ravindranath Kancherla
Executive Director : Venkata Lakshmana Rao Chunduru